Explainers By the Numbers: Road Traffic Crashes Over 90 percent of the world’s fatalities on the roads occur in low-income and middle-income countries, which have less than half of the world’s vehicles.
Expert Q&A Air Pollution: Why Focus on Cities? We work in cities because in addition to hosting some of the biggest air pollution challenges, they hold the most effective solutions.
Expert Q&A Pollution de l’air : pourquoi mettre l’accent sur les villes ? Nous travaillons en étroite collaboration avec les responsables politiques pour renforcer les capacités techniques nécessaires à l’analyse de ces problématiques et à l’élaboration de solutions politiques pour lutter contre les sources de pollution à long terme.
Vital Stories How One City In Brazil Reduced Road Crash Deaths By A Remarkable 40% Fortaleza Mayor Roberto Claudio recently announced that the city of 2.5 million saw a 40 percent reduction in road crash deaths in just four years, from 2014 to 2018.
Press Room São Paulo Combats Drink Driving During Busy Holiday Season The month-long campaign, “Never Drink and Drive,” aims to reach the 8 million drivers in the city through television, radio, social media, billboards and in movie theaters.
Vital Stories In Six Large Cities In Asia, Collaboration Brings New Strategies To Anti-Tobacco Fight Six cities in Asia that have long faced stubbornly high rates of smoking are now learning from each other about how to push towards a healthier future.
Press Room A New Report Shows How Taxing Unhealthy Products Saves Lives New research estimates that 50 million premature deaths could be averted worldwide in the next 50 years if countries increased excise taxes to deliver a 50 percent increase in the prices of tobacco products, alcohol and sugary beverages.
Expert Q&A Vital Stories VitalTalks Q&A With Dr. Tom Frieden We sat down with Dr. Frieden to get his top takeaways on what’s being done to prevent these illnesses, and what steps can be taken to reduce their prevalence and impact.
Vital Stories Results Of Clinical Trial Find Promise In Shorter Drug Treatment Regimen For Multidrug Resistant Tuberculosis The final results of STREAM Stage 1 were recently published in the New England Journal of Medicine, showing the efficacy of a shorter (9–11-month) multidrug-resistant tuberculosis (MDR-TB) treatment regimen in comparison to the longer (20–24-month) regimen which was the standard of care when the trial began.
Press Room Taxing Unhealthy Products Can Save Lives And Help To Fund Universal Health Coverage José Luis Castro, President and CEO of Vital Strategies, issued the following statement to coincide with World Health Day 2019: “Access to health care should be a universal human right, yet half the world’s population lacks essential medical services."